(Date:12/2/2009)... , QUEBEC CITY, Dec. 2 /PRNewswire-FirstCall/ ... (the "Company"), a global biopharmaceutical compa...y announced that the U.S. Food and Drug Administra...the Company,s PI3K/Akt pathway inhibitor compound,...sed/refractory multiple myeloma. Keryx Biopharmace...
(Date:12/1/2009)... , INCLINE VILLAGE, Nev., Dec. 1 /PRNewswire-Fi...LI ) today announced revenue guidance for the four...y $57 million, as compared with $69 million for th...er 2008 results was the first of two installment p...ded in fourth quarter 2008 results was a one-time ...
(Date:12/1/2009)... , CAMBRIDGE, Mass., Dec. 1 /PRNewswire...logy industry and to promote its potential, a grou...tion of the Synthetic Biology Industry Association...he goal of the association is to provide a forum f... the new industry, address its opportunities and i...
(Date:12/1/2009)... , SAN FRANCISCO, Dec. 1 The B...lmost half the value it lost in October. The Selec...excellent month for the general markets with the D... value. The gains held firm in the final two tradi...t sluggish Thanksgiving holiday shopping and Dubai...
Breaking Biology Technology:AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Industry Forms Association to Address Opportunities and Challenges of Synthetic Biology 2Biotech Gets Back on Track in November 2Biotech Gets Back on Track in November 3Biotech Gets Back on Track in November 4...needed to initiate therapy with Pfizer,s recently ...antagonist, MALIBU, Calif., Nov. 15 Pathway Diag... Office (USPTO) has issued U.S. Patent,number 7,29...1 Co-receptor,Use in the Clinical Care of HIV-1-In... the ,458 patent (with rights to sub-license) from...
...d 225.7% year-over-year to $2.3 million or 11 cent...AN CITY, Shandong, China, Nov. 15 /Xinhua-PRNewswi...nk Sheets: CBPO) ("CBP", "the Company"),one of the...the People,s,Republic of China ("PRC"), today repo...r ended on September 30, 2007. Third Quarter 2007...
...15 AlphaMed Press, publisher of the,journal STEM ...Stojkovic as,co-editors. Curt I. Civin, current S...recedented growth in areas of the journal,s most s... published, and number of manuscripts,submitted. D... assisted by,three outgoing senior editors: Alan M...
Other Biology Technology:Pathway Diagnostics Announces Patent Issuance for the Diagnostic Measurement of HIV Tropism for the Initiation or Modification of HIV Therapy 2China Biologic Products Reports Record Third Quarter 2007 Results 2China Biologic Products Reports Record Third Quarter 2007 Results 3China Biologic Products Reports Record Third Quarter 2007 Results 4China Biologic Products Reports Record Third Quarter 2007 Results 5China Biologic Products Reports Record Third Quarter 2007 Results 6China Biologic Products Reports Record Third Quarter 2007 Results 7China Biologic Products Reports Record Third Quarter 2007 Results 8China Biologic Products Reports Record Third Quarter 2007 Results 9China Biologic Products Reports Record Third Quarter 2007 Results 10STEM CELLS Journal Names Co-Editors 2Mouse Anti-14-3-3 Binding Motif, phospho (Ser) Monoclonal Antibody, Unconjugated, Clone 4E2 from Cell Signaling Technology
Rat Anti-acetyl Salicylic Acid Polyclonal Antibody, Unconjugated from Abcam
Rat Anti-Acetyl Salicylic Acid conjugated Acetyl Salicylic Acid Polyclonal Antibody, Unconjugated from Cell Sciences
Rabbit Anti-UBC12 Polyclonal Antibody, Unconjugated from Abcam
Biology Products: